A combination of Roche’s Tecentriq immunotherapy with chemotherapy helped people with a form of lung cancer live significantly longer than patients on chemotherapy alone
ZURICH (Reuters) - A combination of Roche's Tecentriq immunotherapy with chemotherapy helped people with a...